The company’s new product, Arbidol Hydrochloride, was officially approved for market launch on March 19, 2020.


Release date:

2020-04-01

The antiviral product arbidol hydrochloride has played a significant role in the current fight against the epidemic, earning widespread recognition from medical institutions. It is poised to become a mainstay treatment for influenza A, influenza B, and coronaviruses, serving as a new growth driver for the company.

The antiviral product arbidol hydrochloride has played a significant role in the current fight against the epidemic, earning widespread recognition from medical institutions. It is poised to become a mainstay treatment for influenza A, influenza B, and coronaviruses, serving as a new growth driver for the company.


Leave a Message Online

Please fill out the form, and we will get back to you as soon as possible!

Consultation Service Hotline

86-0717-6555905

Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China

International Marketing Department

Contact: Vivian Guo

Email: Vivian.guo@tianrenpharm.com

Phone: 86-15997560212

WhatsApp: +86-15997560212


All rights reserved: Yichang Tianren Pharmaceutical Co., Ltd.

This website supports both IPv4 and IPv6 bidirectional access.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86%EF%BC%8C%E7%9F%A5%E5%90%8D%EF%BC%8C%E7%BA%A7

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home